Abiopharma

XIAO-I CORP (AIXI)

Symbol	AIXI
Name	XIAO-I CORP
Sector	TECHNOLOGY
Region	Asia
Industry	Services-Prepackaged Software
Address	7TH FLOOR, BUILDING 398, SHANGHAI, F4 201803
Telephone	(86) 021-39512112
Fax	—
Email	—
Website	https://www.xiaoi.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001935172
Description	XIAO-I Corp is a global AI industrialization company focusing on AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence and Hyper- automation. Based on the platform, The companyÂ developed products and solutions in fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and service, M&S service, and sale of cloud platform products. Additional info from NASDAQ: XIAO-I Corp is a global AI industrialization company focusing on AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence and Hyper- automation. Based on the platform, The companyÂ developed products and solutions in fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and service, M&S service, and sale of cloud platform products.

2026-09-03 13:15

Xiao-I Corporation Announces ADS Ratio Change with Marketplace Effective Date on September 8, 2026

2026-08-28 17:16

New Form SCHEDULE 13G/A - Xiao-I Corp Filed: 2026-08-28 AccNo: 0001851416-26-000029 Size: 11 KB

2026-08-26 15:23

New Form 424B5 - Xiao-I Corp Filed: 2026-08-26 AccNo: 0001213900-26-093890 Size: 1 MB

2026-08-20 18:14

New Form F-6 POS - Xiao-I Corp Filed: 2026-08-20 AccNo: 0001193805-26-001118 Size: 21 KB

2026-08-20 13:15

Xiao-I Corporation Announces Receipt of Nasdaq Listing Deficiency Notice

2026-08-20 13:15

Xiao-I Corporation Announces Plan to Implement ADS Ratio Change

2026-08-20 10:28

New Form F-6 POS - Xiao-I Corp Filed: 2026-08-20 AccNo: 0001193805-26-001114 Size: 540 KB

2026-07-07 15:16

New Form SCHEDULE 13G/A - Xiao-I Corp Filed: 2026-07-07 AccNo: 0001851416-26-000021 Size: 12 KB

2026-06-30 15:37

New Form 424B5 - Xiao-I Corp Filed: 2026-06-30 AccNo: 0001213900-26-073606 Size: 1 MB

2026-06-19 21:00

Xiao-I Corporation Provides Update on First-Instance Rulings in Patent Litigation Against Apple; Company Intends to Appeal to the Supreme Peoples Court